Lithium |
Mood stabilizer. Reduced gambling thoughts and behaviors in bipolar disorders1919. Antonini A, Cilia R. Behavioral adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention. Drug Saf. 2009;32(6):475-88. https://doi.org/10.2165/00002018-200932060-00004 https://doi.org/https://doi.org/10.2165/...
|
Confusion, somnolence |
Serotonin reuptake inhibitors |
Decreased pursuit of rewards, hypersexuality, and aggression,2020. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Options Neurol. 2012;14(2):126-36. https://doi.org/10.1007/s11940-012-0168-7 https://doi.org/https://doi.org/10.1007/...
improved social and occupational functioning1919. Antonini A, Cilia R. Behavioral adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention. Drug Saf. 2009;32(6):475-88. https://doi.org/10.2165/00002018-200932060-00004 https://doi.org/https://doi.org/10.2165/...
|
Dry mouth, diarrhea, nausea, loss of appetite, headache, somnolence, insomnia, tremor, agitation, sexual dysfunction, asthenia, dizziness, anxiety, nervousness22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
,2020. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Options Neurol. 2012;14(2):126-36. https://doi.org/10.1007/s11940-012-0168-7 https://doi.org/https://doi.org/10.1007/...
|
Levodopa |
Dopamine agonist1919. Antonini A, Cilia R. Behavioral adverse effects of dopaminergic treatments in Parkinson’s disease: incidence, neurobiological basis, management and prevention. Drug Saf. 2009;32(6):475-88. https://doi.org/10.2165/00002018-200932060-00004 https://doi.org/https://doi.org/10.2165/...
|
Dyskinesia, cardiac irregularities, orthostatic hypotensive episodes, psychotic episodes, nausea, depression, urinary retention2020. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Options Neurol. 2012;14(2):126-36. https://doi.org/10.1007/s11940-012-0168-7 https://doi.org/https://doi.org/10.1007/...
|
Rotigotine |
Non-ergot dopamine agonist88. Moretti DV, Binetti G, Zanetti O, Frisoni GB. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatr Dis Treat. 2014;10:1003-9. https://doi.org/10.2147/NDT.S64015 https://doi.org/https://doi.org/10.2147/...
|
Hypotension, nausea, vomiting, somnolence, tachycardia, and dystonia88. Moretti DV, Binetti G, Zanetti O, Frisoni GB. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatr Dis Treat. 2014;10:1003-9. https://doi.org/10.2147/NDT.S64015 https://doi.org/https://doi.org/10.2147/...
|
AChEIs |
Acetylcholinesterase inhibitors1212. Boeve BF, Josephs KA, Drubach DA. Current and future management of the corticobasal syndrome and corticobasal degeneration. Handb Clin Neurol. 2008;89:533-48. https://doi.org/10.1016/s0072-9752(07)01249-3 https://doi.org/https://doi.org/10.1016/...
,1313. Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord. 2007;23(6):351-67. https://doi.org/10.1159/000101337 https://doi.org/https://doi.org/10.1159/...
|
Nausea, vomiting, diarrhea, anorexia, insomnia, fatigue, loss of appetite, weight loss, abdominal pain22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
,2020. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Options Neurol. 2012;14(2):126-36. https://doi.org/10.1007/s11940-012-0168-7 https://doi.org/https://doi.org/10.1007/...
|
Clonazepam |
Hypnotic and anxiolytic |
Drowsiness,22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
,44. Marsili L, Suppa A, Berardelli A, Colosimo C. Therapeutic interventions in parkinsonism: corticobasal degeneration. Parkinsonism Relat Disord. 2016;22(Suppl 1):S96-100. https://doi.org/10.1016/j.parkreldis.2015.09.023 https://doi.org/https://doi.org/10.1016/...
,2121. Reich S, Stephen G. Corticobasal degeneration. Curr Treat Options Neurol. 2009;11(3):179-85. https://doi.org/10.1007/s11940-009-0021-9 https://doi.org/https://doi.org/10.1007/...
behavioral changes, imbalance, incoordination, dizziness,22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
,2121. Reich S, Stephen G. Corticobasal degeneration. Curr Treat Options Neurol. 2009;11(3):179-85. https://doi.org/10.1007/s11940-009-0021-9 https://doi.org/https://doi.org/10.1007/...
tiredness, confusion, memory loss,44. Marsili L, Suppa A, Berardelli A, Colosimo C. Therapeutic interventions in parkinsonism: corticobasal degeneration. Parkinsonism Relat Disord. 2016;22(Suppl 1):S96-100. https://doi.org/10.1016/j.parkreldis.2015.09.023 https://doi.org/https://doi.org/10.1016/...
somnolence, gastrointestinal complaints55. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998;55(7):957-61. https://doi.org/10.1001/archneur.55.7.957 https://doi.org/https://doi.org/10.1001/...
, slurred speech, cognitive impairment, depression2121. Reich S, Stephen G. Corticobasal degeneration. Curr Treat Options Neurol. 2009;11(3):179-85. https://doi.org/10.1007/s11940-009-0021-9 https://doi.org/https://doi.org/10.1007/...
|
Levetiracetam |
Decreased amplitude of cortical somatosensory evoked potentials88. Moretti DV, Binetti G, Zanetti O, Frisoni GB. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatr Dis Treat. 2014;10:1003-9. https://doi.org/10.2147/NDT.S64015 https://doi.org/https://doi.org/10.2147/...
|
Behavioral changes, irritability, fatigue, loss of appetite, dizziness, headache22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
|
Botulinum toxin |
Acetylcholine antagonist |
Excessive weakness22. Armstrong MJ. Diagnosis and treatment of corticobasal degeneration. Curr Treat Options Neurol. 2014;16(3):282. https://doi.org/10.1007/s11940-013-0282-1 https://doi.org/https://doi.org/10.1007/...
|